drugset / Trial / NCT01500811

Autologous Chondrocyte Intra-articular Implantation in Patients With Severe Hip Osteoarthritis

NCT01500811 ↗

Phase 1 Completed 6 enrolled Royan Institute
NaSingle-groupOpen-labelTreatment

Summary

Hip osteoarthritis is degeneration of hip cartilage and inflammation of subchondral bone and soft tissue linings. Patients have pain, stiffness, swelling, and difficulty walking. There are treatments available to help manage these symptoms like weight loss, and analgesics. Surgery is the appropriate treatment in patients who have failed these conservative treatments. The aim of this clinical study is to assess safety of autologous cultured chondrocyte intra-articular injection and obtain its clinical results in patients with severe hip osteoarthritis.

Timeline

Start
2011-03
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject chondrocyte Cell therapy — Other

Indications